Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation-Reference-Cited by-同舟云学术

Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation

Published:2009-05 Issue:5 Volume:84 Page:283-286
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Inamoto Yoshihiro,Kurahashi Shingo,Imahashi Nobuhiko,Fukushima Nobuaki,Adachi Tatsuya,Kinoshita Tomohiro,Tsushita Keitaro,Miyamura Koichi,Naoe Tomoki,Sugiura Isamu

Publisher

Wiley

Subject

Hematology

Reference22 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

2. A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy;Stewart;Leukemia,2007

3. Genetic abnormalities and survival in multiple myeloma: The experience of the Intergroupe Francophone du Myelome;Avet-Loiseau;Blood,2007

4. International staging system for multiple myeloma;Greipp;J Clin Oncol,2005

5. Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis;Gutierrez;Leukemia,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience;Annals of Hematology;2021-03-14

2. Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients;BBA Clinical;2017-12

3. Prognostic Implications of Monosomies in Patients With Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2017-03

4. Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma;Medicine;2016-05

5. Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2015-11